Keyphrases
Chronic Kidney Disease
100%
Hemoglobin
100%
Methodological Issues
100%
Haemoglobin Target
100%
Randomized Controlled Trial
50%
Clinical Practice
50%
Anemia
50%
Patient Characteristics
50%
Nephrology
50%
Incongruity
50%
Optimal Management
50%
Cardiovascular Risk Reduction
50%
Hematocrit
50%
Erythropoiesis-stimulating Agents
50%
Stopping Rule
50%
Epoetin Alfa
50%
Renal Insufficiency
50%
Treatment Allocation
50%
Interim Analysis
50%
Large Trials
50%
Anemia Treatment
50%
Rule Analysis
50%
Systematic Use
50%
Enrollment Criteria
50%
Medicine and Dentistry
Chronic Kidney Disease
100%
Anemia
100%
Cardiovascular Risk
50%
Nephrology
50%
Analeptic
50%
Randomized Controlled Trial
50%
Risk Reduction
50%
Intervention Study
50%
Patient Characteristics
50%
Renal Failure
50%
Hematocrit
50%
Recombinant Erythropoietin
50%
Interim Analysis
50%
Erythropoietin
50%
Nursing and Health Professions
Chronic Kidney Failure
100%
Anemia
100%
Clinical Practice
50%
Kidney Failure
50%
Procrit
50%
Randomization
50%
Central Stimulant Agent
50%
Cardiovascular Risk
50%
Hematocrit
50%
Erythropoietin
50%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
100%
Anemia
100%
Randomized Controlled Trial
50%
Intervention Study
50%
Cardiovascular Risk
50%
Recombinant Erythropoietin
50%
Kidney Failure
50%
Erythropoietin
50%